Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuang Ren

Showing results (211-220 of 216) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 216 results.
Diabetes, Obesity & Metabolism|May 1, 2018
Dorzagliatin (HMS5552), a novel dual-acting glucokinase activator, improves glycaemic control and pancreatic β-cell function in patients with type 2 diabetes: A 28-day treatment study using biomarker-guided patient selectionXiao-Xue Zhu, Da-Long Zhu, Xiao-Ying Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2026
Microvesicle release drives cycles of mitophagy flux disruption and inflammatory amplification in sepsis-induced myocardial dysfunctionRui Song, Yinrui Ma, Junfang Wan, et al.
Journal of Asthma and Allergy|December 15, 2021
A Multicenter Study Assessing Risk Factors and Aeroallergens Sensitization Characteristics in Children with Self-Reported Allergic Rhinitis in ChinaLiting Wu, Wenting Luo, Haisheng Hu, et al.
Journal of Medicinal Chemistry|July 27, 2016
Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid InhibitorsZongxing Qiu, Xianfeng Lin, Mingwei Zhou, et al.
Journal of Medicinal Chemistry|October 16, 2012
Pharmacokinetic optimization of class-selective histone deacetylase inhibitors and identification of associated candidate predictive biomarkers of hepatocellular carcinoma tumor responseJason C Wong, Guozhi Tang, Xihan Wu, et al.
Journal of Medicinal Chemistry|March 25, 2017
Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid InhibitorsZongxing Qiu, Xianfeng Lin, Weixing Zhang, et al.
Pageof 22

Showing results (211-220 of 216) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 216 results.
Diabetes, Obesity & Metabolism|May 1, 2018
Dorzagliatin (HMS5552), a novel dual-acting glucokinase activator, improves glycaemic control and pancreatic β-cell function in patients with type 2 diabetes: A 28-day treatment study using biomarker-guided patient selectionXiao-Xue Zhu, Da-Long Zhu, Xiao-Ying Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2026
Microvesicle release drives cycles of mitophagy flux disruption and inflammatory amplification in sepsis-induced myocardial dysfunctionRui Song, Yinrui Ma, Junfang Wan, et al.
Journal of Asthma and Allergy|December 15, 2021
A Multicenter Study Assessing Risk Factors and Aeroallergens Sensitization Characteristics in Children with Self-Reported Allergic Rhinitis in ChinaLiting Wu, Wenting Luo, Haisheng Hu, et al.
Journal of Medicinal Chemistry|July 27, 2016
Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid InhibitorsZongxing Qiu, Xianfeng Lin, Mingwei Zhou, et al.
Journal of Medicinal Chemistry|October 16, 2012
Pharmacokinetic optimization of class-selective histone deacetylase inhibitors and identification of associated candidate predictive biomarkers of hepatocellular carcinoma tumor responseJason C Wong, Guozhi Tang, Xihan Wu, et al.
Journal of Medicinal Chemistry|March 25, 2017
Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid InhibitorsZongxing Qiu, Xianfeng Lin, Weixing Zhang, et al.
Pageof 22